Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ]: Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012
Tue, July 10, 2012
Mon, July 9, 2012
Fri, July 6, 2012
Thu, July 5, 2012
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ]: Market Wire
Warnex Announces Refinancing

The Lin Law Firm Investigates Potential Breaches of Fiduciary Duties In Connection With Proposed Acquisition of Par Pharmaceuti


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. ith-proposed-acquisition-of-par-pharmaceuti.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

The Lin Law Firm Investigates Potential Breaches of Fiduciary Duties In Connection... -- LOS ANGELES, July 17, 2012 /PRNewswire/ --

The Lin Law Firm Investigates Potential Breaches of Fiduciary Duties In Connection With Proposed Acquisition of Par Pharmaceutical Companies Inc.

[ ]

LOS ANGELES, July 17, 2012 /PRNewswire/ -- The Lin Law Firm, A Professional Law Corporation, is investigating potential breach of fiduciary duty claims against the Board of Directors of Par Pharmaceutical Companies Inc. ("Par Pharmaceutical" or the "Company") (NYSE: [ PRX ]) related to the proposed acquisition of the Company by TPG Capital for $50 per share.

This investigation concerns whether the Board of Directors of Par Pharmaceutical breached its fiduciary duties to shareholders by failing to adequately shop the Company and to obtain the highest price for its shareholders, and whether all material information to shareholders has been disclosed.  The Company has exceeded earnings expectations in three of the last four quarters, and its stock price reached as high as $42.58 on May 2, 2012.  In addition, the price being offered for Par Pharmaceutical shares in the proposed acquisition is low compared to recent deals for generic drug makers. 

If you currently own shares of Par Pharmaceutical and would like to learn more about these claims, or if you wish to discuss these matters and have any questions concerning this announcement or your rights, please contact Elizabeth Lin, Esq., The Lin Law Firm, APLC, by telephone at (866) 864-3898 or by email to [ elizabethL@thelinlawfirm.com ].

The Lin Law Firm, A Professional Law Corporation, is a litigation law firm committed to representing investors nationwide in securities matters and protecting investors against corporate wrongdoing.  For additional information, please visit [ www.thelinlawfirm.com ]. 

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Elizabeth Lin, Esq.
The Lin Law Firm, A Professional Law Corporation
2705 S. Diamond Bar Blvd., Suite 398
Diamond Bar, CA  91765
Tel:  (909) 595-5522 / Toll Free:  (866) 864-3898
Fax:  (909) 595-5519
[ www.thelinlawfirm.com ]

 

SOURCE The Lin Law Firm, A Professional Law Corporation



[ Back to top ]

RELATED LINKS
[ http://www.thelinlawfirm.com ]


Publication Contributing Sources